Clinical Trial Update: Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels [Phase 1, Phase 2]

View source ↗

Summary

NHLBI-sponsored Phase 1/2 clinical trial is evaluating repeat peripheral blood stem cell transplantation for patients with sickle cell disease who are experienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myeloid Chimerism | Phase 1, Phase 2 | Status: RECRUITING